SCHEMBL4341933

SCHEMBL4341933

CCC=CCCCCCCCCCC=CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
F7 P08709 3/20 0.50
F3 P13726 3/20 0.50
CYP19A1 P11511 3/20 0.50
LMNA P02545 3/20 0.50
HSD17B10 Q99714 3/20 0.50
KMT2A Q03164 3/20 0.50
MAPT P10636 2/20 0.50
MEN1 O00255 2/20 0.50
CYP3A4 P08684 2/20 0.50
ALOX15 P16050 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
OXER1 Q8TDS5 2/20 0.50
PTGS1 P23219 2/20 0.50
PPARG P37231 2/20 0.50
PPARD Q03181 2/20 0.50
PPARA Q07869 2/20 0.50
KDM4E B2RXH2 1/20 0.50
FFAR1 O14842 1/20 0.50
NR1I2 O75469 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL538853 1.00 ALDH1A1 (0.50) ALDH1A1F7F3CYP19A1LMNA
SCHEMBL1301319 1.00 ALDH1A1 (0.50) ALDH1A1F7F3CYP19A1LMNA
SCHEMBL4339464 1.00 ALDH1A1 (0.50) ALDH1A1F7F3CYP19A1LMNA
SCHEMBL4335893 1.00 ALDH1A1 (0.50) ALDH1A1F7F3CYP19A1LMNA
SCHEMBL5166020 1.00 ALDH1A1 (0.50) ALDH1A1F7F3CYP19A1LMNA
SCHEMBL8695877 1.00 ALDH1A1 (0.50) ALDH1A1F7F3CYP19A1LMNA
SCHEMBL25327373 1.00 ALDH1A1 (0.50) ALDH1A1F7F3CYP19A1LMNA
SCHEMBL80254 1.00 ALDH1A1 (0.50) ALDH1A1F7F3CYP19A1LMNA
SCHEMBL6438450 1.00 ALDH1A1 (0.50) ALDH1A1F7F3CYP19A1LMNA
SCHEMBL2931992 1.00 ALDH1A1 (0.50) ALDH1A1F7F3CYP19A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009133686-A1 MEDICAMENTS FOR TREATING ALZHEIMER'S DISEASE 有限会社アンティアンティ (JP) 2009-11-05 WO disclosed